Michael Thomas Henderson - Net Worth and Insider Trading
Michael Thomas Henderson Net Worth
The estimated net worth of Michael Thomas Henderson is at least $8 Million dollars as of 2024-05-21. Michael Thomas Henderson is the Chief Business Officer of BridgeBio Pharma Inc and owns about 274,211 shares of BridgeBio Pharma Inc (BBIO) stock worth over $8 Million. Details can be seen in Michael Thomas Henderson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Thomas Henderson has not made any transactions after 2020-12-01 and currently still holds the listed stock(s).
Transaction Summary of Michael Thomas Henderson
Michael Thomas Henderson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Thomas Henderson owns 4 companies in total, including BridgeBio Pharma Inc (BBIO) , ARYA Sciences Acquisition Corp IV (ARYD) , and Spyre Therapeutics Inc (SYRE) among others .
Click here to see the complete history of Michael Thomas Henderson’s form 4 insider trades.
Insider Ownership Summary of Michael Thomas Henderson
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BBIO | BridgeBio Pharma Inc | 2020-12-01 | See Remarks |
ARYD | ARYA Sciences Acquisition Corp IV | 2021-02-25 | director |
SYRE | Spyre Therapeutics Inc | 2023-06-22 | director |
2023-07-13 | director & Chief Executive Officer |
Michael Thomas Henderson Latest Holdings Summary
Michael Thomas Henderson currently owns a total of 1 stock. Michael Thomas Henderson owns 274,211 shares of BridgeBio Pharma Inc (BBIO) as of December 1, 2020, with a value of $8 Million.
Latest Holdings of Michael Thomas Henderson
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BBIO | BridgeBio Pharma Inc | 2020-12-01 | 274,211 | 29.52 | 8,094,709 |
Holding Weightings of Michael Thomas Henderson
Michael Thomas Henderson Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Thomas Henderson has made a total of 18 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 1 buys and 17 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 10,000 shares on December 1, 2020, which brought Michael Thomas Henderson around $515,200.
Insider Trading History of Michael Thomas Henderson
- 1
Michael Thomas Henderson Trading Performance
GuruFocus tracks the stock performance after each of Michael Thomas Henderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Thomas Henderson is -23.64%. GuruFocus also compares Michael Thomas Henderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Thomas Henderson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Thomas Henderson's insider trading performs compared to the benchmark.
Performance of Michael Thomas Henderson
Michael Thomas Henderson Ownership Network
Ownership Network List of Michael Thomas Henderson
Ownership Network Relation of Michael Thomas Henderson
Michael Thomas Henderson Owned Company Details
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Michael Thomas Henderson is the See Remarks of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include Chairman of Oncology Frank Mccormick , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Michael Thomas Henderson made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 999,454 shares made by Neil Kumar , a net sale of 392,710 shares made by Brian C Stephenson , and a net sale of 9,500 shares made by Randal W Scott .
In summary, during the past 3 months, insiders sold 2,500 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 3,010,409 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,010,409 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
Michael Thomas Henderson Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Thomas Henderson. You might contact Michael Thomas Henderson via mailing address: 421 Kipling Street, Palo Alto Ca 94301.